What a Local Sponsor for Clinical Trials Delivers
A local sponsor for clinical trials provides accountable in-country oversight, regulatory coordination and operational control across Asia-Pacific studies.
A local sponsor for clinical trials provides accountable in-country oversight, regulatory coordination and operational control across Asia-Pacific studies.
Decentralised trial management services support patient access across Asia Pacific while safeguarding quality, safety, oversight and sound data integrity.
Clinical trial feasibility in Asia requires local evidence, regulatory insight and site intelligence to support faster, higher-quality study start-up.
Singapore,31-Jul-2026 We would like to share that, at the SCRI Clinical Trials Symposium, Expecto Health Science and the Singapore Clinical Research Institute (SCRI) signed a Memorandum of Understanding (MOU). This…
Singapore, 27-Jul-2026 Expecto is proud to announce the official collaboration with Raffles Hospital Clinical Trials Unit as part of the growing Expecto Flagship Site Network. To mark this significant milestone, representatives from Expecto Health Science presented the official Expecto Flagship…
Expecto Health Science proudly participated in Swiss Biotech Day 2026 as part of the Singapore delegation supported by Enterprise Singapore. The event, held in Basel, brought together over 3,000 industry…
Partnership aims to improve cost-to-deliver, compress timelines, strengthen compliance, and enable faster, evidence-backed decision-making across the clinical development lifecycle Singapore, 09 April 2026 Expecto Health Science, a full-service Asia-Pacific Contract…
Expecto Health Science is pleased to be a part of the ISCR Conference 2026, one of the key gatherings for professionals and leaders in the clinical research industry. The conference…
Singapore, 19 February 2026 – Expecto Health Science, a Singapore-headquartered, Asia-focused clinical research organization (CRO), and Southern Star Research (SSR), a leading Australia-based CRO, today announced a strategic investment-driven partnership.…